NLRP3 inflammasome activation-induced IL-1β and IL-18 in lung cancer may work through mechanisms other than the caspase-1 pathway, indicating that NLRP3 inflammasome can mediate the release of IL-1β and IL-18 through caspase-1-dependent or -independent pathways (69). The gene discussed is IL1B; the disease is lung cancer.